Use of isosulfan blue for identification of lymphatic vessels: experimental and clinical evaluation

AJR. American Journal of Roentgenology
J I HirschM C Beachley

Abstract

Use of vital dyes for identification of lymphatic vessels before cannulation has heretofore not been approved by the Food and Drug Administration (FDA). The suitability of isosulfan blue, the 2,5 disulfonic acid isomer of Patent Blue, for this purpose was evaluated experimentally in the rat and clinically in 11 volunteers and 543 patients under an investigational new drug application. FDA approval for this drug has been obtained. Volunteers and patients received up to 15 mg of a 1% sterile, pyrogen-free solution per extremity (total dose of 0.4 mg/kg in the average patient). Excellent identification of lymphatic vessels was achieved in 100% of volunteers and in 97.4% of patients. In the other 2.6%, lymphatic vessels were not identified mainly due to congenital lymphatic vascular (Milroy) disease. Baseline blood chemistry in volunteers was not altered after administration of the dye. No adverse reactions were found in volunteers and minimal allergic reactions occurred in less than 1% of patients. Acute toxicity studies demonstrated an LD50 greater than 150 mg/kg in the rat. Isosulfan blue was excreted unchanged in the urine (7%) and feces. Comparable excretion was found in volunteers. Isosulfan blue is a safe and efficacious vit...Continue Reading

Citations

Nov 25, 2000·Breast Cancer : the Journal of the Japanese Breast Cancer Society·P I HaighA E Giuliano
Jan 5, 2001·The Surgical Clinics of North America·T J LiuW L Ho
Jan 30, 2002·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Scot A LaurieGeorge Peters
Nov 1, 1991·Annals of Surgery·J H WongD L Morton
Jan 15, 2008·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Sarit CohenHaim Gutman
Aug 9, 2012·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Daniel L J ThorekJan Grimm
Dec 24, 2013·Annals of Vascular Surgery·Andrew M T L ChoongAlexander Loh
Jan 5, 2011·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·V WhiteM Carr
Nov 16, 2010·Surgical Oncology·Corinne BézuSerge Uzan
Apr 10, 2010·Journal of Medical Imaging and Radiation Oncology·A N PlotnikS M Lyon
Sep 18, 2004·Journal of Clinical Anesthesia·M Denise DaleyHenry M Kuerer
Jan 1, 1993·Surgical Oncology·J C Alex, D N Krag
Jun 22, 2001·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·E E Sanidas, D D Tsiftsis
May 26, 2016·AJR. American Journal of Roentgenology·Fei-Fei AnRichard Ting
Oct 19, 2016·Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine·Derya İlem-ÖzdemirMakbule Asikoglu
Jan 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Chandrajit P RautHenry M Kuerer
Jan 14, 2005·The Breast Journal·Ian K KomenakaMahmoud B El-Tamer
Aug 7, 1999·Journal of Vascular Surgery·J Blebea, R Choudry
Oct 6, 2000·Anesthesiology·L Vokach-BrodskyJ G Brock-Utne
Oct 22, 1998·The British Journal of Surgery·S A McIntosh, A D Purushotham
Jun 1, 2005·BJOG : an International Journal of Obstetrics and Gynaecology·Kalyan K Dhar, Robert P Woolas
Jul 30, 2002·Anesthesia and Analgesia·Leslie L MontgomeryPatrick I Borgen
Aug 23, 2017·Journal of Cancer Research and Clinical Oncology·Andrea PapadiaMichael D Mueller

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.